Drreddys Laboratories | GJELD



Debt Endring Dato
ANI Pharmaceuticals USD 624.09M 304.02M 2024-12
Aurora Cannabis CAD 100.98M 11K 2024-12
Bayer EUR 40.7B 465M 2024-12
Canopy Growth CAD 489.67M 123.85M 2024-12
Cipla INR 4.61B 980.3M 2024-09
Corcept Therapeutics USD 0 0 2024-12
Drreddys Laboratories INR 51.08B 2.55B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Hikma Pharmaceutical USD 1.28B 85M 2024-06
Lonza CHF 4.71B 915M 2024-12
Novartis USD 31.26B 828M 2024-12
Pacira USD 585.32M 2.04M 2024-12
Prestige Brands USD 996.95M 54.86M 2024-12
Richter Gedeon HUF 21.74B 1.93B 2024-12
Sun Pharmaceuticals INR 25.72B 7.02B 2024-09
Supernus Pharmaceuticals USD 0 0 2024-12
Teva Pharmaceutical Industries USD 18.08B 901M 2024-12



Drreddys Laboratories GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.